ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628122 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628122; 2) Community: the network communities that were significantly associated with the response to NSC 628122; 3) Molecule: the relationships between components within communities and NSC 628122; 4) MDR: the compounds that were significantly associated with the NSC 628122.

NSC Compound Enrichment Correlation
NSC 126228 Ethanesulfonic acid, compd. with m-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.0285477013888565 0.17629572
NSC 129790 Null 0.0285477013888565 0.060155712
NSC 129794 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.0285477013888565 0.23700158
NSC 13151 Null 0.0285477013888565 0.28397742
NSC 18805 .gamma.-Thujaplicine 0.0285477013888565 0.14524034
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0285477013888565 0.044401533
NSC 300289 Pinafide 0.0285477013888565 0.22243732
NSC 328410 Camptothecin Derivative 0.0285477013888565 0.1780592
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0285477013888565 0.13550126
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0285477013888565 0.16255462
Total:119  Current:84    [First] [Prev] [Next] [Last]